- © Claudio Punzo
- , et al.
Advances in Gene Therapy for Diseases of the Eye
- Claudio Punzo 1
- Hemant Khanna 1
- Lolita Petit 2
- 1 - Department of Neurobiology - University of Massachusetts Medical School - Worcester Massachusetts
- 2 - Department of Ophthalmology and Gene Therapy Center - University of Massachusetts Medical School - Worcester Massachusetts
Jun 24, 2022
Over the last few years, huge progress has been made with regard to the understanding of molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the eye. Such knowledge has led to the development of gene therapy approaches to treat these devastating disorders. Challenges regarding the efficacy and efficiency of therapeutic gene delivery have driven the development of novel therapeutic approaches, which continue to evolve the field of ocular gene therapy. In this review article, we will discuss the evolution of preclinical and clinical strategies that have improved gene therapy in the eye, showing that treatment of vision loss has a bright future.
PrimerOrthogonal Validation in Genome Editing Discovery Work
PrimerSolvent Precipitation Method Increases Protein Recovery for Proteomics
ProtocolPreclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous Disease
ProtocolHigh-Throughput In Vitro, Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction
ProtocolEffective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells